Emerging Markets Report
A Changing of the Guard - Seite 2
A Futures program could be a game changer in the commoditization of cannabis and OWP’s avant-garde approach could be its catalyst. For the record, licenses to grow in Colombia are not as abundant as they are in the United States despite the superior growing opportunity in equatorial Colombia. One World’s opportunity is limited, rare even.
The Company firmly believes it is pioneering the next phase for Cannabis vis-à-vis this Futures program. And now it is has brought in a leader whose name is synonymous with success and whose track
record on and off the court is decorated in achievement.
For more information on One World Pharma please visit:
www.OneWorldPharma.com
About One World Pharma
Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp and cannabis derived ingredients for use in the manufacturing of Medical, Pharmaceutical, Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.
About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.
Lesen Sie auch
For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in
return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock,
restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to
receive in the future certain compensation, as described below.